-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to Q3 2025.
- BridgeBio Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 192M shares, a 1.77% increase year-over-year.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 186M shares, a 14.3% increase from 2023.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 163M shares, a 10.4% increase from 2022.
- BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 147M shares, a 2.16% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)